These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15286952)

  • 1. Angiogenesis and neoplastic transformation of Barrett's epithelium.
    Stein HJ; Möbius C
    Br J Surg; 2004 Aug; 91(8):941-2. PubMed ID: 15286952
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.
    Couvelard A; Paraf F; Gratio V; Scoazec JY; Hénin D; Degott C; Fléjou JF
    J Pathol; 2000 Sep; 192(1):14-8. PubMed ID: 10951394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
    Walch A; Schmitt-Gräff A; Stein H; Werner M
    Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
    Tamayo de la Cuesta JL
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?".
    DeMeester SR
    Am J Gastroenterol; 2010 May; 105(5):1201-2; author reply 1202-3. PubMed ID: 20445513
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
    Morgan G
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitization.
    Eisendrath P; Van Laethem JL
    Gastrointest Endosc; 2002 Feb; 55(2):297-8. PubMed ID: 11845793
    [No Abstract]   [Full Text] [Related]  

  • 8. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ; Spechler SJ
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroesophageal reflux disease and Barrett's esophagus.
    Anand O; Wani S; Sharma P
    Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
    [No Abstract]   [Full Text] [Related]  

  • 11. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there an endobrachy-esophagus cancer sequence?].
    Hameeteman W; Tytgat GN
    Internist (Berl); 1990 Feb; 31(2):119-23. PubMed ID: 2180839
    [No Abstract]   [Full Text] [Related]  

  • 13. Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus.
    Becker V; Vieth M; Bajbouj M; Schmid RM; Meining A
    Endoscopy; 2008 Nov; 40(11):888-91. PubMed ID: 19009480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
    Wilson KT
    Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does symptomatic gastroesophageal reflux present a risk factor for development of adenocarcinoma of the esophagus?].
    Kellner H; Zoller WG
    Z Gastroenterol; 1999 Oct; 37(10):1071-3. PubMed ID: 10549101
    [No Abstract]   [Full Text] [Related]  

  • 16. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology of metaplasia and dysplasia in Barrett's esophagus.
    Yerian L
    Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topic Complex VI: Barrett esophagus].
    Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
    Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplastic precursor lesions in Barrett's esophagus.
    Hornick JL; Odze RD
    Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.